Influenza vaccination: the paediatric perspective.
Influenza in young children represents a significant problem to families and to society, as this population is most susceptible to developing complications and is also a major route of disease spread within communities. However, there is a paucity of European data for the burden of disease in children and the health benefits and cost-effectiveness of vaccination, leading to a lack of awareness by governments, authorities, healthcare professionals and parents. The experience in elderly individuals and the paediatric experience in the US may provide some guidance in developing studies that will provide evidence for the creation of guidelines and educational strategies within Europe.
Ramet
Jose
J
Universitair Ziekenhuis Antwerpen, Department of Paediatrics, UZA & ZNA Koningin Paola Kinderziekenhuis, Antwerp, Belgium. jose.ramet@zna.be
Weil-Olivier
C
C
Sedlak
W
W
D000368:Aged; D002648:Child; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D005190:Family; D017408:Guidelines as Topic; D006266:Health Education; D006801:Humans; D007252:Influenza Vaccines / Q000191:economics / Q000276:immunology*; D014611:Vaccination
D007252:Influenza Vaccines